Welcome to LookChem.com Sign In|Join Free
  • or
2-AMINO-4-METHYLNICOTINIC ACID is a chemical compound with the molecular formula C7H8N2O2, derived from nicotinic acid, which serves as a precursor to the essential coenzyme nicotinamide adenine dinucleotide (NAD+). 2-AMINO-4-METHYLNICOTINIC ACID, is recognized for its potential therapeutic effects, such as anti-inflammatory and antioxidant properties, and is explored for its role in treating various diseases including cancer and diabetes.

38076-82-3

Post Buying Request

38076-82-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

38076-82-3 Usage

Uses

Used in Pharmaceutical Synthesis:
2-AMINO-4-METHYLNICOTINIC ACID is utilized as a key building block in the synthesis of various pharmaceuticals. Its unique structure allows it to be incorporated into the development of new drugs, potentially enhancing their efficacy and targeting specific conditions.
Used in Agrochemical Development:
In the agrochemical industry, 2-AMINO-4-METHYLNICOTINIC ACID is employed for the development of new compounds that can improve crop protection and yield. Its versatility in chemical reactions makes it a valuable component in the creation of novel agrochemicals.
Used in Anti-Inflammatory Applications:
2-AMINO-4-METHYLNICOTINIC ACID has been studied for its anti-inflammatory properties, making it a potential candidate for the treatment of inflammatory conditions. Its ability to modulate inflammatory responses could lead to the development of new therapeutic agents for various inflammatory diseases.
Used in Antioxidant Formulations:
Given its antioxidant properties, 2-AMINO-4-METHYLNICOTINIC ACID is considered for use in antioxidant formulations. Its capacity to neutralize free radicals and protect cells from oxidative damage could contribute to the development of health supplements and treatments for conditions associated with oxidative stress.
Used in Cancer Treatment Research:
2-AMINO-4-METHYLNICOTINIC ACID is under investigation for its potential role in cancer treatment. Its involvement in cellular metabolism and its effects on NAD+ levels suggest that it may have implications for the development of targeted cancer therapies.
Used in Diabetes Management:
Research into 2-AMINO-4-METHYLNICOTINIC ACID's role in the treatment of diabetes is ongoing. Its potential to influence metabolic pathways and glucose regulation positions it as a candidate for the development of new diabetes management strategies.

Check Digit Verification of cas no

The CAS Registry Mumber 38076-82-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,0,7 and 6 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 38076-82:
(7*3)+(6*8)+(5*0)+(4*7)+(3*6)+(2*8)+(1*2)=133
133 % 10 = 3
So 38076-82-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H8N2O2/c1-4-2-3-9-6(8)5(4)7(10)11/h2-3H,1H3,(H2,8,9)(H,10,11)

38076-82-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-amino-4-methylpyridine-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2-Amino-4-methylnicotinic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:38076-82-3 SDS

38076-82-3Downstream Products

38076-82-3Relevant academic research and scientific papers

OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

-

, (2019/09/30)

The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

OXADIAZOLONES AS TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

-

Paragraph 0228-0231, (2018/06/12)

The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 38076-82-3